stockrowOrthoPediatrics Corp. (KIDS) vs Pacific Biosciences of California, Inc. (PACB)
- OrthoPediatrics Corp. KIDS 31.69 −1.64%
- Pacific Biosciences of California, Inc. PACB 2.27 −6.58%
OrthoPediatrics Corp. and Pacific Biosciences of California, Inc. are both Medical Devices companies. OrthoPediatrics Corp. is the larger, with a market value of $841.3M against $755.3M — 1.1× the size. OrthoPediatrics Corp. grew revenue faster over the last twelve months: 16.2% against 4.41%. OrthoPediatrics Corp. has the higher net margin (−12.8% vs −81.3%) and the lower return on invested capital (−3.95% vs 0.00%). Across the 17 metrics below, OrthoPediatrics Corp. leads on 13 and Pacific Biosciences of California, Inc. on 4.
Valuation
Profitability
| Metric | KIDS | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 73.76% | 34.40% | 57.76% |
| Operating margin | (9.39%) | (81.27%) | (14.84%) |
| Net margin | (12.83%) | (81.31%) | (14.45%) |
| Free cash flow margin | 1.20% | (84.85%) | (5.70%) |
| Return on equity | (9.84%) | 1,037.83% | (10.56%) |
| Return on assets | (6.76%) | (17.22%) | (17.26%) |
| Return on invested capital | (3.95%) | 0.00% | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack